Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Sablich Kim
EVP, GM of U.S., Commercial Ma at Jazz Pharmaceuticals. Filing since 11 Nov 2021.
CIK 0001758790
Company
Date
Role
Action
Shares
Amount
Of holding
JAZZ
Jazz Pharmaceuticals plc
8 Mar 2023
EVP, GM of U.S., Commercial Ma
Sold, plan not stated
3,013
$421.04K
9.0%
JAZZ
Jazz Pharmaceuticals plc
7 Jun 2022
EVP & GM, North America
Sold, plan not stated
2,441
$368.71K
9.0%
JAZZ
Jazz Pharmaceuticals plc
6 Jun 2022
EVP & GM, North America
Sold, plan not stated
1,388
$211.18K
4.9%
JAZZ
Jazz Pharmaceuticals plc
11 Nov 2021
EVP & GM, North America
Sold, plan not stated
2,748
$371.00K
11.5%
4 decisions on file.